ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity.

Davide Melisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.